Amorepacific Group has developed a chipless wireless electronic skin that accurately analyzes and measures skin conditions in collaboration with professor Kim Jeehwan of the Massachusetts Institute of Technology (MIT).
The technology, developed after four years of joint research, does away with the use of heavy equipment.
The scholarly publication Science reported the results of this breakthrough.
By making it simpler to identify the skin ailments of people who work in specialized surroundings while being exposed to cold, heat, or dryness, Amorepacific anticipates that this technology will aid in the development of customized functional cosmetics.
Major brands like Sulwhasoo from Amorepacific will leverage the technology developed from this study.
Clinical skin research demands the use of expensive diagnostic tools in addition to sustaining a constant temperature and humidity level.
As a result, there aren't many results from skin research that were obtained in unique circumstances.


AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
AI is driving down the price of knowledge – universities have to rethink what they offer
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Can your cat recognise you by scent? New study shows it’s likely
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears
Neuralink Expands Brain Implant Trials with 12 Global Patients
Japanese Bank Stocks Surge as Bond Yields Fuel Rate Hike Bets
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
OpenAI Agent Breaches Australia Medicare Data Portal
RBI Uses $10 Billion Currency Swaps to Drain Excess Rupee Liquidity
Why have so few atrocities ever been recognised as genocide?
3 clinical-grade skincare creams you really shouldn’t buy online
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 



